[H2 receptor blockaders: domains for oral use. Indications for cimetidine and ranitidine in gastroenterology].
D000284:Administration, Oral; D002927:Cimetidine / Q000627:therapeutic use*; D004382:Duodenitis / Q000188:drug therapy; D004942:Esophagitis, Peptic / Q000188:drug therapy; D010188:Exocrine Pancreatic Insufficiency / Q000188:drug therapy; D005756:Gastritis / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control; D011899:Ranitidine / Q000627:therapeutic use*; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy
D002927:Cimetidine; D011899:Ranitidine
H2-Rezeptorenblocker: Domäne für orale Anwendung. Die Indikationen von Cimetidin und Ranitidin in der Gastroenterologie.